The Current Ratio as of November 2024 (TTM) for Dominari Holdings Inc. (DOMH) is 10.25

According to Dominari Holdings Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.25. This represents a change of -19.66% compared to the average of 12.76 of the last 4 quarters.

Dominari Holdings Inc. (DOMH) Historical Current Ratio (quarterly & annually)

How has DOMH Current Ratio performed in the past?

The mean historical Current Ratio of Dominari Holdings Inc. over the last ten years is 17.56. The current 10.25 Current Ratio has changed 5.74% with respect to the historical average. Over the past ten years (40 quarters), DOMH's Current Ratio was at its highest in in the March 2021 quarter at 184.09. The Current Ratio was at its lowest in in the September 2015 quarter at 0.37.

Dominari Holdings Inc. (DOMH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Dominari Holdings Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dominari Holdings Inc. (DOMH) Average Current Ratio

How has DOMH Current Ratio performed in the past?

The current Current Ratio of Dominari Holdings Inc. (DOMH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Dominari Holdings Inc. (DOMH) Current Ratio vs. Peers

How is DOMH’s Current Ratio compared to its peers?

Dominari Holdings Inc.’s Current Ratio is greater than CytomX Therapeutics, Inc. (1.04), less than Instil Bio, Inc. (12.90), less than Neoleukin Therapeutics, Inc. (15.33), greater than Spero Therapeutics, Inc. (2.68), greater than Assembly Biosciences, Inc. (2.36), greater than Achilles Therapeutics plc (6.04), greater than NextCure, Inc. (9.07), greater than Senti Biosciences, Inc. (1.92), greater than Hillstream BioPharma, Inc. (2.25), greater than SAB Biotherapeutics, Inc. (3.69), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Bolt Biotherapeutics, Inc. (3.16), less than Pasithea Therapeutics Corp. (14.81), less than MediciNova, Inc. (16.66), greater than Fresh Tracks Therapeutics, Inc. (6.98),

Build a custom stock screener for Dominari Holdings Inc. (DOMH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dominari Holdings Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dominari Holdings Inc. (DOMH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dominari Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.